Gepotidacin was approved by the FDA earlier this year, under the Blujepa brand, as the first oral antibiotic to offer a new ...

The word from the FDA is that Prasad has come back at the request of the regulator's Commissioner, Marty Makary, who ...

Boehringer Ingelheim's bid to return to the oncology arena has been achieved with an FDA approval for Hernexeos, a new, ...

Haematological cancers are a recognised potential side effect with Skysona and were already mentioned in a boxed warning on ...

One near-term rival is Johnson & Johnson's FcRn inhibitor nipocalimab, which started a phase 3 programme last December.

One major and often overlooked factor contributing to this imbalance is the way health outcomes are measured in clinical ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

It was that same signal-based approach that we found can be applied to cancer research. A potential new approach to ...

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...

Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...

A jury in the US has found that tech giant Meta illegally compromised the privacy of a US woman who shared her data with a ...

In Part Two, putting theory into practice is addressed.